Skip to content
1 WOMEN'S HEALTHWOMEN'S & REPRODUCTIVE HEALTH

Women's Health Trial Tracker — 2010

RecordRecord DateVuga GroupChange StatusRecency DaysResearch Attention Score
Colposcopy Versus HPV Testing to Identify Persistent Cervical Precancers01/20/2010INTERVENTIONALnot-comparable6,107.750
Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer02/12/2010INTERVENTIONALnot-comparable6,084.750
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer03/05/2010INTERVENTIONALnot-comparable6,063.750
Extending the National Health Service (NHS) Breast Screening Age Range03/05/2010INTERVENTIONALnot-comparable6,063.750
Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer03/05/2010INTERVENTIONALnot-comparable6,063.750
Positron Emission Tomography in Women With Advanced HER2-Positive Breast Cancer03/26/2010INTERVENTIONALnot-comparable6,042.750
Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer05/05/2010INTERVENTIONALnot-comparable6,002.750
Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life05/31/2010OBSERVATIONALnot-comparable5,976.750
Excision Followed by Radiofrequency Ablation for Breast Cancer06/29/2010INTERVENTIONALnot-comparable5,947.750
Teriparatide (PTH) and Bone Strength in Postmenopausal Women07/01/2010OBSERVATIONALnot-comparable5,945.750
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer07/22/2010INTERVENTIONALnot-comparable5,924.750
Predictive Assays In Cervix Cancer08/13/2010INTERVENTIONALnot-comparable5,902.750
Rehabilitation of Cognitive Changes in Breast Cancer Survivors08/16/2010INTERVENTIONALnot-comparable5,899.750
Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors09/09/2010INTERVENTIONALnot-comparable5,875.750
Relaxation for Women With Breast Cancer Undergoing Radiotherapy09/16/2010INTERVENTIONALnot-comparable5,868.750
Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast Cancer09/16/2010INTERVENTIONALnot-comparable5,868.750
Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer10/29/2010INTERVENTIONALnot-comparable5,825.750
Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer11/19/2010INTERVENTIONALnot-comparable5,804.750
Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer11/22/2010INTERVENTIONALnot-comparable5,801.750
National Pregnancy Registry for Psychiatric Medications11/23/2010OBSERVATIONALnot-comparable5,800.750
Standard or Hypofractionated Radiotherapy Versus Accelerated Partial Breast Irradiation (APBI) for Breast Cancer11/24/2010INTERVENTIONALnot-comparable5,799.750
Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer12/24/2010INTERVENTIONALnot-comparable5,769.750